Pre-existing neutralizing antibody provides the first line of defence against pathogens in
general. For influenza virus, annual vaccinations are given to maintain protective levels of …

The 2009 pandemic H1N1 influenza pandemic demonstrated the global health threat of
reassortant influenza strains. Herein, we report a detailed analysis of plasmablast and …

Emerging evidence indicates a central role for the microbiome in immunity. However, causal
evidence in humans is sparse. Here, we administered broad-spectrum antibiotics to healthy …

Zika virus (ZIKV) is an emerging mosquito-borne flavivirus of significant public health concern.
ZIKV shares a high degree of sequence and structural homology compared with other …

Class switch recombination (CSR) is a region-specific DNA recombination reaction that replaces
one immunoglobulin heavy-chain constant region (Ch) gene with another. This enables …

Each B-cell receptor consists of a pair of heavy and light chains. High-throughput sequencing
can identify large numbers of heavy- and light-chain variable regions (V H and V L ) in a …

We describe herein a protocol for the production of antigen-specific human monoclonal
antibodies (hmAbs). Antibody-secreting cells (ASCs) are isolated from whole blood collected 7 d …

Immunoglobulin A (IgA) is prominently secreted at mucosal surfaces and coats a fraction of
the intestinal microbiota. However, the commensal bacteria bound by IgA are poorly …

During immune responses, antibodies are selected for their ability to bind to foreign antigens
with high affinity, in part by their ability to undergo homotypic bivalent binding. However, …

H3N2 viruses continuously acquire mutations in the hemagglutinin (HA) glycoprotein that
abrogate binding of human antibodies. During the 2014–2015 influenza season, clade 3C.2a …